HC Deb 17 December 1992 vol 216 cc419-20W
Mr. David Nicholson

To ask the Secretary of State for Health if she will list the membership and terms of reference of the Advisory Committee on Borderline Substances.

Dr. Mawhinney

The members of the advisory committee are:


Professor Harry A. Lee

Professor of Renal Medicine (University of Southampton), Consultant Physician (St. Mary's Hospital, Portsmouth)


Dr. Charles L. M. Beardmore

General Practitioner (Walton-On-the-Naze, Essex)

Professor Ian W. Booth

Senior Lecturer in Paediatrics and Child Health, Professor of Paediatric Gastroenterology and Nutrition (University of Birmingham)

Ms. Julie Fenton

Senior Dietitian (Normansfield, Teddington)

Dr. Anne Kobza Black

Consultant Dermatologist (St. John's Hospital for Diseases of the Skin), (Royal Throat, Nose and Ear Hospital, London)

Professor Andrew H. G. Love

Professor of Medicine (Queen's University, Belfast); Consultant Physician (Royal Victoria Hospital, Belfast).

Mrs. Anita MacDonald

Chief Paediatric Dietitian (Children's Hospital, Birmingham).

Mr. Graeme Millar

Community Pharmacist (Edinburgh).

Dr. Gwyn W. Phillips

General Practitioner (Pencoed, Mid-Glamorgan).

Professor Alan Shenkin

Professor of Clinical Chemistry (Royal Liverpool Hospital).

Dr. Richard S. Tiner

General Practitioner (Taunton, Somerset)

The committee's current terms of reference are: To keep under review the principles for determining whether preparations should properly be regarded as drugs, foods, toilet preparations or disinfectants, and to give advice on the classifications of particular preparations in these categories submitted to the Committee.

My right hon. Friend the Secretary of State announced on 12 November that the committee's remit is extended to have regard to comparative cost as well as therapeutic use when considering whether an item should be treated as a drug appropriate for prescription by general practitioners under the national health service. Revised terms of reference, to reflect this change, will be announced shortly.

Forward to